Patrick D. Spangler's most recent trade in OptimizeRx Corp was a trade of 9,868 Common Stock done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Patrick D. Spangler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 9,868 | 55,335 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 13,286 | 45,467 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 10,061 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 10,061 | 32,181 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 10,061 | 10,061 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 4,637 | 22,120 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 4,637 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 657 | 657 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 657 | 17,483 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 409 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 409 | 16,826 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2022 | 334 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2022 | 334 | 16,417 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 4,637 | 4,637 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 657 | 657 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Sale of securities on an exchange or to another person at price $ 84.38 per share. | 11 Nov 2021 | 6,252 | 16,083 (0%) | 0% | 84.4 | 527,544 | Common Stock (pursuant to 10B5-1 plan) |
| OptimizeRx Corp | Patrick D. Spangler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2021 | 334 | 334 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 407 | 22,335 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Patrick D. Spangler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 539 | 21,928 (0%) | 0% | 0 | Common Stock |